Novel Digital Exercise Prescription Tool P3-EX Enters Feasibility Trial for Cardiovascular Risk Management — What Clinicians Need to Know

References

1. 1.Lee, I. M., Shiroma, E. J., Lobelo, F., Puska, P., Blair, S. N., & Katzmarzyk, P. T. (2012). Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. The Lancet, 380(9838), 219-229. https://doi.org/10.1016/S0140-6736(12)61031-9
2. 2.Lobelo, F., Stoutenberg, M., & Hutber, A. (2014). The evidence in support of physicians and health care providers as physical activity counselors. American Journal of Lifestyle Medicine, 8(5), 295-298. https://doi.org/10.1177/1559827613520120
3. 3.Naci, H., & Ioannidis, J. P. (2013). Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ, 347, f5577. https://doi.org/10.1136/bmj.f5577
4. 4.Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., ... & Olson, R. D. (2018). The Physical Activity Guidelines for Americans. JAMA, 320(19), 2020-2028. https://doi.org/10.1001/jama.2018.14854
5. 5.University of Connecticut. (2024). Feasibility and Acceptability of a Novel Algorithm for Physicians to Prescribe Personalized Exercise Prescriptions to Patients With Cardiovascular Disease Risk Factors. ClinicalTrials.gov. NCT07238556. https://clinicaltrials.gov/study/NCT07238556
6. 6.Warburton, D. E., & Bredin, S. S. (2017). Health benefits of physical activity: a systematic review of current systematic reviews. Current Opinion in Cardiology, 32(5), 541-556. https://doi.org/10.1097/HCO.0000000000000437